课题基金 / 基金详情

Neonatal Resuscitation with Intact Cord (NRIC)

Neonatal Resuscitation with Intact Cord (NRIC)
新生儿脐带完整复苏 (NRIC)
批准号:
8882489
负责人:
Anup C Katheria
金额:
$15.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-01 至 2016-06-30

项目摘要

项目成果

Anup C Katheria的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Premature babies are at risk for bleeding in their brain, referred to as intraventricular hemorrhage (IVH), which often results in developmental delays or other neurological problems such as cerebral palsy. Delaying the time at which the umbilical cord is clamped after birth by 30-60 seconds has been shown to reduce IVH and has become the standard of care in the delivery of preterm infants. However, delayed cord clamping (DCC) does not reduce severe IVH, which may be due to inadequate placental transfusion in infants at risk for severe IVH. A recent study (Bhatt et al.) compared DCC to immediate cord clamping (ICC) in ventilated lambs and found DCC prevented a rapid increase in carotid artery pressure while increasing pulmonary blood flow (PBF) to the lungs. The majority of infants at risk for severe IVH (compromised and extremely premature infants) are born by cesarean section (C/S) and therefore do not receive the benefit of passage through the birth canal, which facilitates fluid clearance from the newborn lungs and increases PBF. Previous studies have demonstrated suboptimal placental transfusion (via hematocrit levels) from DCC for infants born by C/S. Opening the premature infant's lungs with ventilation during DCC could increase placental transfusion, thereby improving PBF and facilitating physiological transition. Ventilation during the period of DCC in the delivery room is not currently practiced. A sterile T-piece will be used to achieve lung recruitment simultaneously with placental transfusion from DCC. We will test the hypothesis that a simple sterile ventilation circuit (with which we have extensive experience) can be employed with no impediment to obstetrical care and provide benefit to the premature infant during DCC. Specific Aims: 1) Compare the volume of placental transfusion with ventilation during delayed cord clamping (V-DCC) to delayed cord clamping alone (DCC) between infants born by C/S or vaginal delivery (VD). 2) Compare the physiological changes in the first 6 hours of life (HOL) between infants born by C/S or VD randomized to V-DCC or to DCC alone. 3) Compare the clinical outcomes between infants born by either C/S or VD, randomized to V-DCC or to DCC alone. 4) Compare the effects of mode of delivery on volume of placental transfusion, physiological changes, and clinical outcomes between all 4 groups. Design: This is a blinded randomized controlled clinical trial. Both groups will receive the same resuscitation interventions once the umbilical cord is clamped. Brain oxygenation and cardiac output will be continuously measured beginning in the delivery room until 6 HOL. An early heart ultrasound will be performed (<6 HOL) to measure systemic blood flow and detect fetal shunts. Adequacy of placental transfusion will be assessed by 12 HOL hematocrit. Clinicians will be blinded to whether the infant did or did not receive ventilation during DCC. This will be the first blinded randomized study to evaluate the effect of ventilation on DCC in very preterm infants delivered by C/S with a comparison group of VD preterm infants randomized to the same interventions.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Sharp Neonatal Research Institute Clinical Center (Sharp NRI-CC)
  • 批准号:
    10683030
  • 项目类别:
  • 资助金额:
    $33.95万
  • 财政年份:
    2023
  • 负责人:
    Anup C Katheria
  • 依托单位:
Delayed Cord Clamping with Oxygen In Extremely Low Gestational Age Infants (DOXIE)
  • 批准号:
    10549378
  • 项目类别:
  • 资助金额:
    $7.72万
  • 财政年份:
    2022
  • 负责人:
    Anup C Katheria
  • 依托单位:
Delayed Cord Clamping with Oxygen In Extremely Low Gestational Age Infants (DOXIE)
  • 批准号:
    10373881
  • 项目类别:
  • 资助金额:
    $7.72万
  • 财政年份:
    2022
  • 负责人:
    Anup C Katheria
  • 依托单位:
The NICU Antibiotics and Outcomes (NANO) Trial